Czeisler J L, el-Rashidy R M
J Pharm Sci. 1985 Jul;74(7):750-4. doi: 10.1002/jps.2600740711.
We have found evidence that an intramolecular hydrogen bond exists between the amido and pyridine groups of disopyramide in aqueous solutions. This conclusion was reached by a comparison of the pKa values for the basic nitrogen atoms of certain analogues of disopyramide. By comparing the pharmacological actions of disopyramide with those of pheniramine, which lacks an amido group, we have concluded that the constraint on the rotation of the pyridine ring which is imposed by the hydrogen bond is a major determinant of the antiarrhythmic activity. That constraint is, at the same time, a suppressor of the anticholinergic activity. We then concluded that a covalent link would hold the pyridine ring, and the amido group, in the desirable conformation permanently, which would lead to better antiarrhythmic activity and a lower degree of anticholinergic activity. Pharmacological studies on such new molecules are in general agreement with these concepts.
我们发现有证据表明,在水溶液中,丙吡胺的酰胺基和吡啶基之间存在分子内氢键。这一结论是通过比较丙吡胺某些类似物碱性氮原子的pKa值得出的。通过比较丙吡胺与缺乏酰胺基的苯海拉明的药理作用,我们得出结论,氢键对吡啶环旋转的限制是抗心律失常活性的主要决定因素。同时,这种限制也是抗胆碱能活性的抑制剂。然后我们得出结论,共价键将使吡啶环和酰胺基永久保持在理想的构象中,这将导致更好的抗心律失常活性和更低程度的抗胆碱能活性。对这类新分子的药理研究总体上与这些概念一致。